Morbidity and Mortality Weekly Report (MMWR)

Active Epilepsy and Seizure Control in Adults — United States, 2013 and 2015
April 20, 2018
The prevalence of active epilepsy in the United States was 1.1% (approximately 2.6 million adults) during 2013 and 2015, and was significantly higher in 2015 (1.2%) than in 2013 (0.9%). Forty-four percent of adults with active epilepsy who took epilepsy medication had their seizures controlled in the past year.
Suicidal Ideation and Attempts Among Students in Grades 8, 10, and 12 — Utah, 2015
April 20, 2018
A 2015 survey in Utah indicated that approximately 20% of 8th, 10th, and 12th grade students reported suicidal thoughts and 8% attempted suicide in the previous year.

Heart Disease Death Rates Among Blacks and Whites Aged ≥35 Years — United States, 1968–2015
March 30, 2018
Heart disease is the leading cause of death in the United States. In 2015, heart disease accounted for approximately 630,000 deaths, representing one in four deaths in the United States. Although heart disease death rates decreased 68% for the total population from 1968 to 2015, marked disparities in decreases exist by race and state. This report demonstrates the use of data from the National Vital Statistics System to conduct surveillance of heart disease death rates by race and of black-white disparities in heart disease death rates among adults aged ≥35 years for 1968–2015.

Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
January 12, 2018
This report updates and summarizes previously published recommendations from the Advisory Committee on Immunization Practices (ACIP) and CDC regarding the prevention of hepatitis B virus (HBV) infection in the United States. These recommendations also provide CDC guidance for postexposure prophylaxis following occupational and other exposures. This report also briefly summarizes previously published American Association for the Study of Liver Disease guidelines for maternal antiviral therapy to reduce perinatal HBV transmission.